302
Participants
Start Date
September 1, 2021
Primary Completion Date
August 1, 2024
Study Completion Date
August 1, 2027
Oxaliplatin+S-1
"Drug: Oxaliplatin Oxaliplatin: 130mg/m2,iv drip for 2h,d1, q3w~Drug: S-1 S-1: 40\~60mg Bid,d1\~14, q3w"
Sinitilimab+oxaliplatin+S-1
"Drug: Sintilimab Sintilimab, recombinant humanized anti-PD-1 monoclonal antibody for injection; 200mg ivdrip, d1, q3w.~Other Name: PD-1 antibody~Drug: Oxaliplatin Oxaliplatin: 130mg/m2,iv drip for 2h,d1, q3w~Drug: S-1 S-1: 40\~60mg Bid,d1\~14, q3w"
RECRUITING
The sixth affiliated hospital of Sun Yat-sen University, Guangzhou
Sun Yat-sen University
OTHER
Sixth Affiliated Hospital, Sun Yat-sen University
OTHER